Accessibility settings

Published on in Vol 10 (2026)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/69098, first published .
Diverse hands holding a red heart and stethoscope, symbolizing healthcare and unity.

Bidirectional Automated Texting for Cardiovascular Health Among People Living With HIV: Observational Cohort Analysis of a Stepped-Wedge Cluster Randomized Controlled Trial

Bidirectional Automated Texting for Cardiovascular Health Among People Living With HIV: Observational Cohort Analysis of a Stepped-Wedge Cluster Randomized Controlled Trial

1Department of Family Medicine, University of Rochester Medical Center, Rochester, NY, United States

2Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, United States

3Clinical Directors Network, New York, NY, United States

4Department of Biostatistics, University of Rochester Medical Center, Rochester, NY, United States

5The Rockefeller University, The Rockefeller University Center for Clinical and Translational Science, New York, NY, United States

Corresponding Author:

Mechelle Sanders, PhD


Background: Feasible and potentially scalable strategies are needed to address the growing cardiovascular disease (CVD) risk among people living with HIV. Bidirectional automated texting (BAT) programs that remind and encourage adherence to evidence-based CVD-reducing interventions represent a potentially scalable strategy, but data on their feasibility are lacking.

Objective: The goal of the study was to determine whether participant sociodemographic factors and technological constraints influenced engagement with a BAT CVD prevention program by people living with HIV. We conducted an observational cohort analysis embedded within a stepped-wedge cluster randomized trial.

Methods: The BAT program was designed to address the “Million Hearts” ABCS (aspirin therapy, blood pressure control, cholesterol management, and smoking cessation) of cardiovascular health. The parent study was a stepped-wedge randomized trial that rolled out in 3 wedges across 8 practice sites that provided care to people living with HIV. Participants received and could engage with the text messages weekly using their own phones during the study period. We used a zero-inflated negative binomial model to identify factors associated with participants sending text messages during the study.

Results: Of the 471 participants, 94% owned a smartphone capable of text messaging, and 70% reported monthly incomes less than US $1500. Overall, 60.3% (n=284) engaged with the BAT program at least once. Regarding texting behavior, participants aged ≥65 years were more likely to send a text than those aged <50 years (P=.047), although age did not influence the number of texts sent. White participants showed lower texting intensity than Black participants (incidence rate ratio 0.69; P=.04).

Conclusions: Overall, 60.3% (n=284) of the participants in the study engaged with BAT at least once. The BAT intervention for ABCS appears to be a feasible intervention for people living with HIV. Only a few factors were associated with sending a text or with the number of text messages sent.

Trial Registration: ClinicalTrials.gov NCT03902431; https://clinicaltrials.gov/study/NCT03902431

JMIR Cardio 2026;10:e69098

doi:10.2196/69098

Keywords



Use of highly effective antiretroviral therapy has dramatically reduced deaths from AIDS-related causes, yielding an aging population among people living with HIV [1,2]. Cardiovascular disease (CVD) risk is up to 2 times greater among people living with HIV compared with the general population [3,4]. Bidirectional automated texting (BAT) has been successfully used for multiple types of health interventions, including tobacco cessation, blood pressure control, cancer screening, medication adherence, and HIV treatment [5-10]. BAT allows users to respond to confirm medical appointments, answer questions, report symptoms, and share health updates in real time or at their convenience, enabling efficient and ongoing asynchronous communication between patients and their health care team [5-7]. BAT can also be used to collect health information through text messages. It is a potentially scalable tool for communicating with patients outside the clinical encounter while enabling the provision of tailored information based on responses to prior text messages [8].

A systematic review found that text-messaging programs for CVD can help people better manage their heart disease risk factors [9]. Given this, the growing risk of CVD among people living with HIV may be substantively reduced by using evidence-based BAT programs that remind and encourage adherence to evidence-based CVD-reducing interventions [10]. Compared with other types of engagement, texting offers potentially higher reach relative to cost and is scalable due to its low marginal costs once established [10-13]. Beyond the general efficacy, specific trials have also explored the practical utility and user acceptance of texting interventions for preventing and managing CVD [14,15]. For example, in one study, participants received 1 text per week about general CVD knowledge, blood pressure control, medication adherence, physical activity, healthy diet, and smoking cessation (only for smokers). The findings highlighted strong user satisfaction, with nearly all participants reporting that the text messages were useful (96.1%), easy to understand (98.8%), and appropriate in frequency (93.8%). Participants also reported a high willingness to receive future messages (94.8%) [16].

Several studies have shown that text messaging can improve medication adherence and appointment attendance [17-21]. However, evidence for its impact on sexually transmitted infection and HIV prevention and treatment remains mixed [22,23]. McLaughlin et al [24] proposed a framework for creating educational text messages around primary prevention of CVD in people living with HIV, but randomized trials are still needed to confirm its effectiveness. To address this gap, we analyzed feasibility data from an observational cohort nested within a stepped-wedge trial to identify factors influencing engagement among people living with HIV with CVD prevention text messages.


Population

The HIV ABCS (aspirin therapy, blood pressure control, cholesterol management, and smoking cessation) trial, which was part of PRECluDE (Implementation Research to Develop Interventions for People Living With HIV), a consortium of National Heart, Lung, and Blood Institute funded trials, has been previously described (ClinicalTrials.gov NCT03902431) [25,26]. Participants were recruited from 8 geographically diverse sites across 3 locations: 4 in New York City, New York; 2 in Rochester, New York; and 2 in Dallas, Texas. These sites included academic medical centers, freestanding HIV practices, and Federally Qualified Health Centers (FQHCs). Participants were eligible if they had English or Spanish language proficiency sufficient to read text messages and a personal mobile phone. We enrolled 471 participants aged 40 to 75 years (by July 1, 2018) with a 10-year atherosclerotic CVD (ASCVD) risk of at least 5% without known cardiovascular or cerebrovascular disease (eg, stroke, myocardial infarction, and coronary artery disease), based on eligibility criteria from the ASCVD risk calculator [27].

Intervention

This study was an observational cohort nested within the parent stepped-wedge trial. The parent stepped-wedge trial was conducted between 2019 and 2023. This design used a multicomponent strategy to promote the uptake of the US Department of Health and Human Services’ “Million Hearts” ABCS campaign for cardiovascular health [28]. This design involved 8 sites divided into 3 wedges, with each wedge separated by 6 to 8 months.

For the patient-facing component, BAT messages were delivered by a commercial vendor (Mosio). To develop the BAT for CVD prevention for people living with HIV, we generated a library of evidence-based text messages for each of the ABCS. The messages included potential behavior change techniques, knowledge about the ABCS, personal affirmation, self-efficacy, adherence support, and the importance of goal commitment (Figure 1). Mosio sent messages in either English or Spanish, depending on participants’ language preferences.

Figure 1. Examples of goal-setting text messages sent to the participants in the HIV ABCS (aspirin therapy, blood pressure control, cholesterol management, and smoking cessation) and their responses at different time points.

Participants engaged with these text messages for a maximum of 6 months, regardless of their assigned wedge. Message frequency was initially set at 1 to 3 texts per day for the first 4 months, then tapered to 1 to 2 texts per week. This frequency was also adaptive, with additional texts sent based on participant responses to prompts, such as indicating a need for more information or incorrect answers to CVD knowledge checks. This was embedded in the program’s branching logic. To encourage sustained engagement throughout the 6-month texting period, participants were eligible for 3 US $5 incentives (up to US $15 overall) if they responded to specific text messages that were randomly selected from the automated message library [29].

Demographic and Psychosocial Variables

Research assistants collected data from participants on sex at birth, race, ethnicity, preferred language, and income. Participants also reported their chronic conditions (hypertension or diabetes) and completed validated scales: the Patient Activation Measure (PAM), the Confusion, Hubbub, and Order Scale (CHAOS), and the Subjective Numeracy Scale (SNS) [30-32]. The PAM assessed patients’ knowledge, skills, and confidence in managing their health. The CHAOS scale evaluated household environment disorganization and its potential impact on texting behaviors, while the SNS measured patients’ abilities to understand and use health-related information effectively. Together, these instruments provided a comprehensive assessment of factors influencing self-management and texting engagement. Both the PAM and SNS have been evaluated in similar populations [33,34].

Smartphone and Text Message Use and Skills

We developed 8 questions to evaluate participants’ smartphone use and skills, covering ownership, length of use, acquisition type, self-rated skill level, frequency of service interruption, ability to text during interruptions, and time since the last interruption. For instance, participants reported years of smartphone ownership or use, with options ranging from “0‐3 years” to “more than 7 years.” Participants also rated their smartphone skill from “Beginner” (limited to calls and texts) to “Expert” (full proficiency, including settings). Phone acquisition options included “Purchase,” “Gift,” or “Government Plan.” Participants indicated how they paid for their data service plan (eg, postpaid, prepaid, limited minutes, or other options). The frequency of phone or data service interruptions was assessed with options ranging from “every month by the first week” to “never.” Finally, the survey asked about unlimited texting capability and the ability to receive texts during service interruptions, with “Yes,” “No,” and “Unsure” as response options.

Texting Engagement

Previous studies of text-messaging interventions have shown that outcomes often follow a dose-response pattern, where greater engagement can lead to larger improvements in the variables of interest [35-37]. To assess patient engagement with BAT, we counted the number of text messages patients sent. We created two engagement measures: (1) a binary indicator of any engagement (sent at least 1 message vs no messages) and (2) a continuous count of messages among participants who sent at least 1 message.

ABCS Goal Choice

We identified the participants’ ABCS goal based on their report within the BAT system. Participants specifically reported the goal that they had discussed and mutually agreed upon with their clinician.

Data Analysis

We performed all analyses using R (version 4.4.2; R Foundation for Statistical Computing). All statistical tests were 2-tailed and based on a 5% significance level. We calculated descriptive statistics and presented these as means and SDs where appropriate.

We used a zero-inflated negative binomial (ZINB) model to assess factors associated with participants sending a text. Our model accounted for excess zeros (eg, never sending a text) and overdispersion. Covariates for the model were selected using a 2-step process: first, variables were screened for predictive importance using Bayesian additive regression trees (BART) with the threshold of 0.4; second, the final model included variables identified by BART as well as standard sociodemographic adjusters (eg, age, race, and sex) important to the study design and supported by existing literature. Ethnicity was screened out by the BART procedure and was not retained in the final model owing to its collinearity with race. The count model examined the frequency of texts sent among those who sent at least 1 text (incidence rate ratio), while the inflation model predicted the likelihood of never sending a text versus sending any texts (odds ratio).

Ethical Considerations

The study was approved by the institutional review board at the University of Rochester Medical Center (approval number STUDY00003679), with reliance review at each of the participating sites. Informed consent was obtained from each participant. Participants could receive up to US $80 for this study: US $40 for the baseline visit, US $10 for the second visit, US $15 for the third visit, and up to an additional US $15 (3 US $5 cards) for responding to randomly incentivized text messages, which were provided at the second or third visit.


Participants

The participants were middle-aged, that is, 55 years or older (336/470, 71.5%), male (321/471, 68.2%), and Black (273/470, 58.1%). Among participants with available income data, 48.7% (211/433) reported a monthly household income of less than US $1000 per month (Table 1).

Table 1. Baseline participant characteristicsa.
CharacteristicsParticipants
Demographics
Age (y; n=470), n (%)
  40‐4950 (10.6)
50‐5484 (17.9)
55‐59134 (28.5)
  60‐64114 (24.3)
≥6588 (18.7)
Education (n=443), n (%)
  Less than high school107 (24.2)
  High school graduate141 (31.8)
Higher than high school195 (44)
Monthly household income (US $; n=433), n (%)
  <1000211 (48.7)
  1000‐149989 (20.6)
  1500‐199955 (12.7)
  >200078 (18)
Sex at birth (n=471), n (%)
Male321 (68.2)
  Female149 (31.6)
  Decline to state1 (0.2)
Race (n=470), n (%)
  Black or African American273 (58.1)
  White136 (28.9)
Other61 (13)
Ethnicity (Hispanic or Latino; n=434), n (%)87 (20)
Clinical characteristics
Blood pressure at baseline (mm Hg), mean (SD)
Systolic (n=470)135.32 (18.2)
Diastolic (n=464)82.52 (10.7)
Treated for hypertension (n=470), n (%)293 (62.3)
Has diabetes (n=470), n (%)154 (32.8)
Smoking status (n=470), n (%)
Current195 (41.5)
  Never147 (31.3)
Former128 (27.2)
Regular aspirin use (n=465), n (%)104 (22.4)
Treated with statin (n=466), n (%)266 (57.1)
Total cholesterol (mg/dL; n=470), mean (SD)186.2 (37.5)
Survey measures, mean (SD)
Health literacy score (n=412)4.48 (1.3)
Subjective Numeracy Scale score (1-6; n=446)3.94 (1.0)
Confusion, Hubbub, and Order Scale score (0‐30; n=433)13.98 (4.3)
Patient Activation Measure raw score (13-52; n=447)43.55 (5.9)
Technology access and skills
Own or have access to a smartphone (n=446), n (%)417 (93.5)
Duration of owning or using a smartphone (y; n=439), n (%)
  0‐3141 (32.1)
  4‐7103 (23.5)
  >7195 (44.4)
Smartphone acquisition (n=446), n (%)
 Purchased359 (80.5)
 Gift72 (16.1)
 Government plan15 (3.4)
Self-rated smartphone skill (n=439), n (%)
  Beginner (calls and text only)117 (26.7)
  Advanced beginner (calls and text and internet search)60 (13.7)
  Intermediate (calls and texts, internet search, and downloading apps)110 (25.1)
Advanced (calls and texts, internet search, downloading apps, and changing settings and passwords)75 (17.1)
  Expert (all of the skills and more)77 (17.6)
Phone or data service interruption frequency (n=444), n (%)
  Every month, first week34 (7.8)
Every month, second week8 (1.8)
Every month, third week11 (2.5)
  Rarely87 (19.6)
  Never304 (68.5)
Unlimited texting capability (n=446), n (%)383 (85.9)
Able to receive texts when service interrupted (n=441), n (%)211 (47.8)
Service interrupted in past 4 months (n=314), n (%)31 (9.9)
ABCSb goal choice (n=448), n (%)
 Aspirin28 (6.3)
 Blood pressure136 (30.4)
Cholesterol169 (37.8)
 Smoking115 (25.8)
Primary outcome measure
Did the participant send a text message? (n=471), n (%)284 (60.3)
Message count (among those that sent a text; n=284), mean (SD)29.26 (34.2)
Participants per site (n=471), n (%) 
Site 1109 (23.1)
Site 243 (9.1)
Site 357 (12.1)
Site 440 (8.5)
Site 531 (6.7)
Site 642 (8.9)
Site 7110 (23.4)
Site 839 (8.3)

aThe sample sizes vary across variables because not all participants provided responses for every measure, including missing data in electronic health records.

bABCS: aspirin therapy, blood pressure control, cholesterol management, and smoking cessation.

A total of 93.5% (417/446) of participants owned smartphones and 32.1% (141/439) had owned or used one for ≤3 years. Most participants (359/446, 80.5%) purchased their phone, whereas 3.4% (15/446) received it through a government plan. Most participants (304/444, 68.5%) never had service interruptions. Self-rated smartphone skills varied, with 26.7% (117/439) reporting being beginners and 34.6% (152/439) as advanced or expert (Table 1).

ZINB Model

Out of a total of 39 potential variables, BART selected 5 (12.8%) variables as important predictors of texting: smoking status, clinical practice site, self-rated smartphone skill, length of smartphone use, and final goal (ABCS), but none of the 4 survey measures. Together with age, sex, and race, the final model included 8 independent predictors. We fit the ZINB model to the text count outcome and the above 8 key covariates, after excluding 38 participants due to missing data (Table 2).

Table 2. Zero-Inflation model: predictors of texting engagementa.
PredictorNever texted, ORb (95% CI)P valueText count, IRRc (95% CI)P value
Age (y)
<50Referenced
50‐540.63 (0.24-1.67).361.13 (0.61-2.09).71
55‐590.56 (0.23-1.40).211.28 (0.72-2.27).44
60‐640.78 (0.30-2.00).610.87 (0.48-1.56).64
650.33 (0.11-0.99).0470.80 (0.44-1.47).48
Sex
FemaleReference
Male0.78 (0.42-1.46).440.81 (0.58-1.12).22
Race
Black or African AmericanReference
White0.65 (0.30-1.44).290.69 (0.49-0.98).04
Other1.14 (0.51-2.54).740.84 (0.54-1.31).44
Smoking status
CurrentReference
Former1.33 (0.59-2.99).491.18 (0.77-1.79).45
Never1.32 (0.61-2.82).481.02 (0.67-1.51).92
Study site
Site 1Reference
Site 20.91 (0.38-2.19).840.55 (0.28-1.08).08
30.22 (0.08-0.59).0030.34 (0.18-0.62)<.001
40.14 (0.04-0.46).0010.36 (0.20-0.63)<.001
50.54 (0.20-1.48).230.67 (0.32-1.39).28
60.20 (0.07-0.59).0040.76 (0.42-1.37).36
70.08 (0.03-0.21)<.0011.23 (0.81-1.89).33
80.09 (0.02-0.40).0020.59 (0.34-1.02).06
Self-rated smartphone skill
BeginnerReference
Advanced beginner0.76 (0.33-1.79).531.19 (0.76-1.84).45
Intermediate0.70 (0.33-1.47).351.33 (0.88-2.00).18
Advanced0.74 (0.30-1.83).521.19 (0.75-1.89).46
Expert0.39 (0.14-1.09).071.20 (0.77-1.85).42
Length of smartphone use (y)
<4Reference
4‐70.91 (0.45-1.83).791.27 (0.87-1.86).22
>70.72 (0.36-1.43).341.04 (0.74-1.46).81
ABCSe goal
CholesterolReference
Aspirin0.25 (0.07-0.83).021.45 (0.83-2.51).19
Blood pressure0.86 (0.46-1.61).630.90 (0.65-1.25).53
Smoking1.39 (0.59-3.25).451.06 (0.68-1.64).80

aThe point estimate for the natural logarithm of the size parameter in the statistical model was −0.03 (95% CI −0.26 to 0.19; P=.77).

bOR: odds ratio.

cIRR: incidence rate ratio.

dReference category (zero inflation).

eABCS: aspirin therapy, blood pressure control, cholesterol management, and smoking cessation.

The odds of ever texting were 3-fold higher for participants aged ≥65 years than those aged <50 years (P=.047). However, age was not associated with the number of texts sent among participants who sent at least 1 text. Regarding race, we observed no statistically significant impact on whether a participant ever sent a text. However, among those who texted, White participants sent approximately 31% fewer text messages than Black participants (P=.04). Participants at 5 sites were more likely to send at least 1 text compared with those at the reference site. However, among participants who texted at least once, those from two of these same sites sent fewer text messages.


Principal Results

This study explored factors affecting people living with HIV engagement with a BAT CVD prevention texting program among people living with HIV. In our ZINB model, older age, HIV care site, and selecting aspirin as a goal were associated with texting participation. The association between site and texting engagement warrants further investigation. It is not clear why, after controlling for patient-level factors, participants at 5 sites were more likely to send at least 1 text, and why those at 2 of these sites who texted at least once sent fewer text messages. This unexpected finding may serve as a surrogate for unmeasured site-specific factors such as differences in staffing, changes in on-site technical support for texting, prior digital health experience, or the quality of study implementation. These unmeasured factors may have been stronger predictors of engagement than patient-level demographic characteristics. The association with aspirin may reflect the complexity of the 2016 US Preventive Services Task Force’s aspirin recommendations: “The USPSTF recommends initiating low-dose aspirin use for the primary prevention of cardiovascular disease (CVD) and colorectal cancer in adults aged 50 to 59 years who have a 10% or greater 10-year CVD risk, are not at increased risk for bleeding, have a life expectancy of at least 10 years, and are willing to take low-dose aspirin daily for at least 10 years [38].” Participants selecting aspirin may have texted more due to this added complexity. While our data cannot definitively assess these explanations, future research incorporating qualitative methods could investigate these contextual factors more deeply.

Comparison With Prior Work

Our results align with previous studies demonstrating BAT is feasible and readily used among historically lower digitally literate participants, that is, those who are older, have low income, and have less education [39]. Our results also reflect the marked increase in smartphone ownership across all demographic groups, consistent with broader trends reported in the literature [40]. Our analysis included primarily participants who did not report monthly interruptions in mobile phone service. This approach allowed us to examine patient engagement within a cohort largely free from connectivity challenges, which previous studies have identified as a significant barrier [41,42]. Building on prior work by our group and others that indicates the feasibility of providing digital literacy training to low-income people living with HIV [43,44], our findings further support the potential for technology-assisted interventions to increase engagement with care. This suggests a promising avenue for future intervention development, potentially increasing engagement with care, and facilitating the evaluation of both effectiveness and implementation outcomes.

While race did not significantly influence the likelihood of a participant sending any text, we observed that among those who did text, White participants sent fewer text messages than Black participants. This finding is consistent with earlier data from 2010 showing that Black and Hispanic individuals who use text messaging text more on average than White individuals, with a median of 10 text messages per day for Black and Hispanic individuals compared with 5 text messages per day for White individuals [10]. To mitigate language barriers a priori, our research staff who enrolled Spanish-speaking patients were bilingual, and BAT messages were translated and back-translated into Spanish. However, our subsample of Spanish-speaking patients was modest, and we cannot rule out the need for further cultural or linguistic adaptations to the text messages.

Limitations and Strengths

One limitation of this study is the lack of qualitative data at the patient, clinician, and site levels. We were limited to quantitative information and may have missed important contextual factors that could help explain the differences observed across sites. For example, at the start of the intervention, participants were able to self-select the best time of day to receive texts. However, participants’ preferred texting times may have changed over time (eg, due to changes in employment hours), potentially limiting their ability to engage with the intervention. Additionally, it is possible that participants saw the texts, read them, and decided not to engage with the text. Lack of engagement does not necessarily preclude them from following through with their ABCS goals. In univariate analyses, we observed that participants experiencing service interruptions were less likely to send messages (P<.001). However, neither service interruption variable was important in the BART variable selection procedure after adjusting for the other key variables. Importantly, although we adopted a complete-case analysis in the ZINB model, the BART procedure performs feature selection without this assumption under a missing at random assumption and, therefore, did not remove records with missing values when selecting important features. However, the BART method for handling missing data is biased toward the null, which implies that BART would tend to shrink a nonnegligible correlation closer to zero in the presence of missing data [45]. Consequently, our measure of engagement may underestimate true engagement among those facing connectivity challenges. The prevalence of service interruptions itself may be underestimated if those most affected were also less likely to report them. The study used modest random monetary incentives to increase texting engagement, with participants able to receive an additional US $15 for responding to randomly incentivized messages during the 6-month intervention. This approach may have influenced their motivation to text, and it is unclear whether this motivation would persist in a real-world setting without such incentives. Moreover, we were unable to control for these random incentives in our analysis, making them a potential confounder for the number of texts sent. A separate limitation is that we were unable to control for the adaptive logic of the text messaging (eg, additional prompts based on responses), which may have biased the estimated associations with texting frequency or engagement.

Despite these limitations, the strengths of our study include the availability of both Spanish and English versions of the text messages, a geographically diverse participant population, multiple types of care settings (eg, FQHCs and academic health centers), and a large sample size that enhances the generalizability of the findings.

Conclusions

A BAT intervention for the ABCS of heart health appears to be a promising tool for engaging people living with HIV. Overall, 60.3% (284/471) of the participants in the study were able to engage with the texting platform at least once. Surprisingly, few factors were associated with sending a text or with the number of text messages sent.

BAT is feasible to implement among low-income people living with HIV. Future studies should examine contextual factors that may have influenced engagement but were not captured in our research, particularly the role of personal assistance. Given the increasing reliance on text messaging by health systems for patient communication (eg, scheduling, reminders, and results), future efforts should explore how BAT interventions can be integrated into clinical workflows to reinforce CVD prevention, particularly among patients with low incomes.

Acknowledgments

The authors gratefully acknowledge the invaluable contributions of their collaborating partners and organizations whose participation made this investigation possible: Joseph P. Addabbo Health Center (Queens, New York); Morris Heights Health Center (Bronx, New York); Brownsville Multi-specialty Practice (Brooklyn, New York); Family Health Centers at New York University Langone–Sunset Terrace Health Center (Brooklyn, New York); Bluitt-Flowers Health Clinic (Dallas, Texas); Amelia Court Clinic (Dallas, Texas); University of Rochester Medical Center AIDS Center (Rochester, New York); and Trillium Health (Rochester, New York). The authors also extend their appreciation to the National Heart, Lung, and Blood Institute Center for Translation Research and Implementation Science staff, including Cheryl Boyce, PhD; Mary Masterson, PhD; Rebecca Roper, MS, MPH, EdD; and Veronica Tutse-Tonwe, MSHS, PMP, for their guidance and support. Finally, the authors thank the members of the Data and Safety Monitoring Board—Anita Vaughn, MD; Katherine Freeman, DrPH; and David Young—for their oversight and commitment throughout the study. Grammarly was used for copyediting assistance with the final manuscript, and Qualified Health AI was used to confirm that the authors' responses to the reviewers' comments were adequate.

Funding

This study was funded by the National Heart, Lung, and Blood Institute through grant U01HL142107, beginning in 2018. The project described in this publication was also supported by the University of Rochester Clinical and Translational Science Award (CTSA), award UL1 TR002001, from the National Center for Advancing Translational Sciences of the National Institutes of Health. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Data Availability

The datasets generated or analyzed during this study are not publicly available due to participant confidentiality but can be made available by the corresponding author upon reasonable request.

Authors' Contributions

KF and JNT contributed to funding acquisition. MS, KF, and JNT contributed to the conceptualization and methodology of this study. BJ and DH contributed to data curation and investigation. MS contributed to writing the original draft. MS, KF, JNT, ES, TH, MT, YT, and AC contributed to analysis review and validation. AC, ES, TH, and MT contributed to project administration. All authors contributed to writing, review, and editing and approved the submitted manuscript.

Conflicts of Interest

None declared.

  1. Trickey A, Sabin CA, Burkholder G, et al. Life expectancy after 2015 of adults with HIV on long-term antiretroviral therapy in Europe and North America: a collaborative analysis of cohort studies. Lancet HIV. May 2023;10(5):e295-e307. [CrossRef] [Medline]
  2. Trickey A, McGinnis K, Gill MJ, et al. Longitudinal trends in causes of death among adults with HIV on antiretroviral therapy in Europe and North America from 1996 to 2020: a collaboration of cohort studies. Lancet HIV. Mar 2024;11(3):e176-e185. [CrossRef] [Medline]
  3. Alonso A, Barnes AE, Guest JL, Shah A, Shao IY, Marconi V. HIV infection and incidence of cardiovascular diseases: an analysis of a large healthcare database. J Am Heart Assoc. Jul 16, 2019;8(14):e012241. [CrossRef] [Medline]
  4. Losina E, Hyle EP, Borre ED, et al. Projecting 10-year, 20-year, and lifetime risks of cardiovascular disease in persons living with human immunodeficiency virus in the United States. Clin Infect Dis. Oct 15, 2017;65(8):1266-1271. [CrossRef] [Medline]
  5. Ingersoll K, Dillingham R, Reynolds G, et al. Development of a personalized bidirectional text messaging tool for HIV adherence assessment and intervention among substance abusers. J Subst Abuse Treat. Jan 2014;46(1):66-73. [CrossRef] [Medline]
  6. Donovan G, Hall N, Ling J, Smith F, Wilkes S. Influencing medication taking behaviors using automated two‐way digital communication: a narrative synthesis systematic review informed by the Behavior Change Wheel. Br J Health Psychol. Sep 2022;27(3):861-890. [CrossRef]
  7. Arambepola C, Ricci-Cabello I, Manikavasagam P, Roberts N, French DP, Farmer A. The impact of automated brief messages promoting lifestyle changes delivered via mobile devices to people with type 2 diabetes: a systematic literature review and meta-analysis of controlled trials. J Med Internet Res. Apr 19, 2016;18(4):e86. [CrossRef] [Medline]
  8. Abroms LC, Whittaker R, Free C, Mendel Van Alstyne J, Schindler-Ruwisch JM. Developing and pretesting a text messaging program for health behavior change: recommended steps. JMIR Mhealth Uhealth. Dec 21, 2015;3(4):e107. [CrossRef] [Medline]
  9. Calderon Martinez E, Zachariah Saji S, Salazar Ore JV, et al. Text messages as a tool to improve cardiovascular disease risk factors control: a systematic review and meta-analysis of randomized clinical trials. BMC Public Health. Apr 4, 2025;25(1):1284. [CrossRef] [Medline]
  10. Hall AK, Cole-Lewis H, Bernhardt JM. Mobile text messaging for health: a systematic review of reviews. Annu Rev Public Health. Mar 18, 2015;36:393-415. [CrossRef] [Medline]
  11. Leong KC, Chen WS, Leong KW, et al. The use of text messaging to improve attendance in primary care: a randomized controlled trial. Fam Pract. Dec 2006;23(6):699-705. [CrossRef] [Medline]
  12. Chen ZW, Fang LZ, Chen LY, Dai HL. Comparison of an SMS text messaging and phone reminder to improve attendance at a health promotion center: a randomized controlled trial. J Zhejiang Univ Sci B. Jan 2008;9(1):34-38. [CrossRef] [Medline]
  13. Siopis G, Moschonis G, Eweka E, et al. Effectiveness, reach, uptake, and feasibility of digital health interventions for adults with hypertension: a systematic review and meta-analysis of randomised controlled trials. Lancet Digit Health. Mar 2023;5(3):e144-e159. [CrossRef] [Medline]
  14. Shariful Islam SM, Farmer AJ, Bobrow K, et al. Mobile phone text-messaging interventions aimed to prevent cardiovascular diseases (Text2PreventCVD): systematic review and individual patient data meta-analysis. Open Heart. 2019;6(2):e001017. [CrossRef] [Medline]
  15. Ricci-Cabello I, Bobrow K, Islam SM, et al. Examining development processes for text messaging interventions to prevent cardiovascular disease: systematic literature review. JMIR Mhealth Uhealth. Mar 29, 2019;7(3):e12191. [CrossRef] [Medline]
  16. Zheng X, Spatz ES, Bai X, et al. Effect of text messaging on risk factor management in patients with coronary heart disease: the CHAT randomized clinical trial. Circ Cardiovasc Qual Outcomes. Apr 2019;12(4):e005616. [CrossRef] [Medline]
  17. Ershad Sarabi R, Sadoughi F, Jamshidi Orak R, Bahaadinbeigy K. The effectiveness of mobile phone text messaging in improving medication adherence for patients with chronic diseases: a systematic review. Iran Red Crescent Med J. 2016;18(5):e25183. [CrossRef] [Medline]
  18. DeKoekkoek T, Given B, Given CW, Ridenour K, Schueller M, Spoelstra SL. mHealth SMS text messaging interventions and to promote medication adherence: an integrative review. J Clin Nurs. Oct 2015;24(19-20):2722-2735. [CrossRef] [Medline]
  19. Thakkar J, Kurup R, Laba TL, et al. Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis. JAMA Intern Med. Mar 2016;176(3):340-349. [CrossRef] [Medline]
  20. Zhao YY, Dang FP, Zhai TT, Li HJ, Wang RJ, Ren JJ. The effect of text message reminders on medication adherence among patients with coronary heart disease: a systematic review and meta-analysis. Medicine (Baltimore). Dec 2019;98(52):e18353. [CrossRef] [Medline]
  21. Kannisto KA, Koivunen MH, Välimäki MA. Use of mobile phone text message reminders in health care services: a narrative literature review. J Med Internet Res. Oct 17, 2014;16(10):e222. [CrossRef] [Medline]
  22. Mbuagbaw L, Mursleen S, Lytvyn L, Smieja M, Dolovich L, Thabane L. Mobile phone text messaging interventions for HIV and other chronic diseases: an overview of systematic reviews and framework for evidence transfer. BMC Health Serv Res. Jan 22, 2015;15:33. [CrossRef] [Medline]
  23. Taylor D, Lunny C, Lolić P, et al. Effectiveness of text messaging interventions on prevention, detection, treatment, and knowledge outcomes for sexually transmitted infections (STIs)/HIV: a systematic review and meta-analysis. Syst Rev. Jan 8, 2019;8(1):12. [CrossRef] [Medline]
  24. McLaughlin MM, Hsue PY, Lowe DA, Olgin JE, Beatty AL. Development of text messages for primary prevention of cardiovascular disease in persons with HIV. Cardiovasc Digit Health J. 2023;4(6):191-197. [CrossRef] [Medline]
  25. Williams SK, Johnson BA, Tobin JN, et al. Protocol paper: stepped wedge cluster randomized trial translating the ABCS into optimizing cardiovascular care for people living with HIV. Prog Cardiovasc Dis. 2020;63(2):125-133. [CrossRef] [Medline]
  26. Gamble-George JC, Longenecker CT, Webel AR, et al. ImPlementation REsearCh to DEvelop Interventions for People Living with HIV (the PRECluDE consortium): combatting chronic disease comorbidities in HIV populations through implementation research. Prog Cardiovasc Dis. 2020;63(2):79-91. [CrossRef] [Medline]
  27. Lloyd-Jones DM, Huffman MD, Karmali KN, et al. Estimating longitudinal risks and benefits from cardiovascular preventive therapies among Medicare patients: the Million Hearts Longitudinal ASCVD Risk Assessment Tool: a special report from the American Heart Association and American College of Cardiology. J Am Coll Cardiol. Mar 28, 2017;69(12):1617-1636. [CrossRef] [Medline]
  28. Frieden TR, Berwick DM. The “Million Hearts” initiative--preventing heart attacks and strokes. N Engl J Med. Sep 29, 2011;365(13):e27. [CrossRef] [Medline]
  29. Suffoletto B. Deceptively simple yet profoundly impactful: text messaging interventions to support health. J Med Internet Res. Aug 27, 2024;26:e58726. [CrossRef] [Medline]
  30. Hibbard JH, Stockard J, Mahoney ER, Tusler M. Development of the Patient Activation Measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Serv Res. Aug 2004;39(4 Pt 1):1005-1026. [CrossRef] [Medline]
  31. Fagerlin A, Zikmund-Fisher BJ, Ubel PA, Jankovic A, Derry HA, Smith DM. Measuring numeracy without a math test: development of the Subjective Numeracy Scale. Med Decis Making. 2007;27(5):672-680. [CrossRef] [Medline]
  32. Matheny AP, Wachs TD, Ludwig JL, Phillips K. Bringing order out of chaos: psychometric characteristics of the Confusion, Hubbub, and Order Scale. J Appl Dev Psychol. Jul 1995;16(3):429-444. [CrossRef]
  33. Fiscella K, Boyd M, Brown J, et al. Activation of persons living with HIV for treatment, the great study. BMC Public Health. Oct 16, 2015;15:1056. [CrossRef] [Medline]
  34. Sanders M, Tobin JN, Cassells A, et al. Can a brief peer-led group training intervention improve health literacy in persons living with HIV? Results from a randomized controlled trial. Patient Educ Couns. May 2021;104(5):1176-1182. [CrossRef] [Medline]
  35. Mattila E, Lappalainen R, Välkkynen P, et al. Usage and dose response of a mobile Acceptance and Commitment Therapy app: secondary analysis of the intervention arm of a randomized controlled trial. JMIR Mhealth Uhealth. Jul 28, 2016;4(3):e90. [CrossRef] [Medline]
  36. Li Y, Guo Y, Hong YA, et al. Dose-response effects of patient engagement on health outcomes in an mHealth intervention: secondary analysis of a randomized controlled trial. JMIR Mhealth Uhealth. Jan 4, 2022;10(1):e25586. [CrossRef] [Medline]
  37. McVay MA, Bennett GG, Steinberg D, Voils CI. Dose-response research in digital health interventions: concepts, considerations, and challenges. Health Psychol. Dec 2019;38(12):1168-1174. [CrossRef] [Medline]
  38. Bibbins-Domingo K, U.S. Preventive Services Task Force. Aspirin use for the primary prevention of cardiovascular disease and colorectal cancer: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. Jun 21, 2016;164(12):836-845. [CrossRef] [Medline]
  39. Brar Prayaga R, Agrawal R, Nguyen B, et al. Impact of social determinants of health and demographics on refill requests by Medicare patients using a conversational artificial intelligence text messaging solution: cross-sectional study. JMIR Mhealth Uhealth. Nov 18, 2019;7(11):e15771. [CrossRef] [Medline]
  40. Rashid A, Zeb MA, Rashid A, Anwar S, Joaquim F, Halim Z. Conceptualization of smartphone usage and feature preferences among various demographics. Cluster Comput. Sep 2020;23(3):1855-1873. [CrossRef]
  41. Read GL, Yan HY, Anderson PB, et al. Making stability dependable: stable cellphone access leads to better health outcomes for those experiencing poverty. Inf Commun Soc. 2022;25(14):2122-2139. [CrossRef]
  42. Krishna S, Boren SA, Balas EA. Healthcare via cell phones: a systematic review. Telemed J E Health. Apr 2009;15(3):231-240. [CrossRef] [Medline]
  43. Carroll JK, Tobin JN, Luque A, et al. “Get Ready and Empowered About Treatment” (GREAT) study: a pragmatic randomized controlled trial of activation in persons living with HIV. J Gen Intern Med. Sep 2019;34(9):1782-1789. [CrossRef] [Medline]
  44. Ngiam NH, Yee WQ, Teo N, et al. Building digital literacy in older adults of low socioeconomic status in Singapore (Project Wire Up): nonrandomized controlled trial. J Med Internet Res. Dec 2, 2022;24(12):e40341. [CrossRef] [Medline]
  45. Sparapani R, Spanbauer C, McCulloch R. Nonparametric machine learning and efficient computation with Bayesian additive regression trees: the BART R package. J Stat Softw. 2021;97(1):1-66. [CrossRef]


ABCS: aspirin therapy, blood pressure control, cholesterol management, and smoking cessation
ASCVD: atherosclerotic cardiovascular disease
BART: Bayesian additive regression trees
BAT: bidirectional automated texting
CHAOS: Confusion, Hubbub, and Order Scale
CVD: cardiovascular disease
FQHC: Federally Qualified Health Center
PAM: Patient Activation Measure
SNS: Subjective Numeracy Scale
ZINB: zero-inflated negative binomial


Edited by Andrew Coristine; submitted 21.Nov.2024; peer-reviewed by Anderson Bermon, Sintieh Ekongefeyin; final revised version received 27.Apr.2026; accepted 30.Apr.2026; published 14.Jul.2026.

Copyright

© Mechelle Sanders, Donald Harrington, Emma Sass, Marie Thomas, Tameir Holder, Yiqi Tian, Brent Johnson, Andrea Cassells, Jonathan N Tobin, Kevin Fiscella. Originally published in JMIR Cardio (https://cardio.jmir.org), 14.Jul.2026.

This is an open-access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work, first published in JMIR Cardio, is properly cited. The complete bibliographic information, a link to the original publication on https://cardio.jmir.org, as well as this copyright and license information must be included.